Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study
暂无分享,去创建一个
Stephen E. Jones | R. Rudick | B. Trapp | E. Fisher | Kunio Nakamura | H. Battapady | S. Staugaitis | D. Ontaneda | R. Fox | Megan Vignos | A. Chang | S. Mørk | Jacqueline T. Chen | J. Dudman | S. Jones | Harsha Battapady
[1] D. Norris,et al. Nonlinear temporal dynamics of cerebral small vessel disease , 2017, Neurology.
[2] B. Uitdehaag,et al. Outcome Measures in Clinical Trials for Multiple Sclerosis , 2017, CNS Drugs.
[3] O. Ciccarelli,et al. MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES , 2016, The Lancet Neurology.
[4] P. Voorn,et al. Neuronal and Axonal Loss in Normal-Appearing Gray Matter and Subpial Lesions in Multiple Sclerosis , 2015, Journal of neuropathology and experimental neurology.
[5] M. Sormani,et al. MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials , 2013, The Lancet Neurology.
[6] Peter A. Calabresi,et al. Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis , 2012, PloS one.
[7] P. Matthews,et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.
[8] Robert Fox,et al. CLADA: Cortical longitudinal atrophy detection algorithm , 2011, NeuroImage.
[9] R. Reynolds,et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis , 2010, Annals of neurology.
[10] M. Battaglini,et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.
[11] M Rovaris,et al. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics? , 2009, Multiple sclerosis.
[12] R. Rudick,et al. Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.
[13] David H. Miller,et al. Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.
[14] B. Trapp,et al. Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.
[15] R. Rudick,et al. Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions , 2008, Annals of neurology.
[16] Elizabeth Fisher,et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains , 2007, Annals of neurology.
[17] P. Matthews,et al. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.
[18] G Tedeschi,et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.
[19] Sridar Narayanan,et al. The role of edema and demyelination in chronic T1 black holes: A quantitative magnetization transfer study , 2005, Journal of magnetic resonance imaging : JMRI.
[20] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[21] A J Thompson,et al. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis , 2003, Multiple sclerosis.
[22] A. Dale,et al. Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.
[23] P. M. Matthews,et al. Evidence of early cortical atrophy in MS , 2003, Neurology.
[24] J H Simon,et al. Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.
[25] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[26] F Barkhof,et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.
[27] J. Duda,et al. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1a , 2000, Multiple sclerosis.
[28] R. Rudick,et al. Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.
[29] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.